Keryx drug improves phosphorus, iron in kidney patients -trial
July 24, 2014 at 17:00 PM EDT
July 24 (Reuters) - A pivotal trial of Keryx Biopharmaceuticals Inc's experimental drug Zerenex showed that it improved levels of serum phosphorus and iron in patients on kidney dialysis, according to results published on Thursday.